The fifth WHO update released in 2021 organized the degree of malignancy of adult-type diffuse gliomas into astrocytoma, IDH-mutant; oligodendroglioma, IDH-mutant and 1p/19q-codeleted; and glioblastoma, IDH-wildtype3. This evidence concerns the gene IDH1 and oligodendroglioma.